502609-47-4

Basic information

• Product Name: 4-HydroxyMethyl-4-Methyltetrahydro-2H-pyran
• Synonyms: 4-HydroxyMethyl-4-Methyltetrahydro-2H-pyran;4-(HydroxyMethyl)-4-Methyltetrahydropyran;(4-Methyl-tetrahydro-pyran-4-yl)-methanol;(4-methyltetrahydro-2H-pyran-4-yl)methanol
• CAS NO: 502609-47-4
• Molecular Formula: C7H14O2
• Molecular Weight: 130.18486
• Mol File: 502609-47-4.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 211.7±8.0 °C(Predicted)
• Appearance: /
• Density: 0.967±0.06 g/cm3(Predicted)
• PKA: 14.85±0.10(Predicted)
• CAS DataBase Reference: 4-HydroxyMethyl-4-Methyltetrahydro-2H-pyran(CAS DataBase Reference)
• NIST Chemistry Reference: 4-HydroxyMethyl-4-Methyltetrahydro-2H-pyran(502609-47-4)
• EPA Substance Registry System: 4-HydroxyMethyl-4-Methyltetrahydro-2H-pyran(502609-47-4)

Safety Data

• Hazardous Substances Data: 502609-47-4(Hazardous Substances Data)

Usage

General Description

4-HydroxyMethyl-4-Methyltetrahydro-2H-pyran, also known as 4-hydroxymethyl-4-methyl-2,3,5,6-tetrahydro-2H-pyran, is an organic compound with the molecular formula C6H12O2. It is a colorless liquid with a mildly sweet odor and is commonly used as a flavor and fragrance additive in the food and beverage industry. It is also used as a building block in the synthesis of various pharmaceutical drugs and other organic compounds. The compound is produced through chemical synthesis and has been found to have low toxicity, making it safe for use in consumer products when used in appropriate concentrations.

Upstream product

• 110238-91-0 tetrahydropyran-4-carboxylic acid methyl ester 
• 443912-70-7 methyl 4-methyltetrahydro-2H-pyran-4-carboxylate 
• 861161-92-4 ethyl 4-methyltetrahydro-2H-pyran-4-carboxylate 
• 96835-17-5 ethyl tetrahydro-2H-pyran-4-carboxylate 

Downstream Products

• 65626-22-4 4-methyltetrahydro-2H-pyran-4-carbaldehyde 

Relevant articles and documents

3-(1H-PYRAZOL-4-YL)PYRIDINE ALLOSTERIC MODULATORS OF M4 MUSCARINIC ACETYLCHOLINE RECEPTOR

Provided are cinnolinyl and quinolinyl pyrazol-4-yl-pyridine compounds which are allosteric modulators of the M4 muscarinic acetylcholine receptor, compositions comprising said compounds, and uses of said compounds in the treatment or prevention of diseases in which M4 muscarinic acetylcholine receptors are involved, especially neurological and psychiatric disorders and diseases.

HYDROXYL PURINE COMPOUNDS AND USE THEREOF

Disclosed are a series of hydroxyl purine compounds and the use thereof as PDE2 or TNFα inhibitors, in particular, the compounds as shown in formula (I), or tautomers or pharmaceutically acceptable salts thereof.

HETEROCYCLIC MODULATORS OF LIPID SYNTHESIS AND COMBINATIONS THEREOF

Heterocyclic modulators of lipid synthesis are provided as well as pharmaceutically acceptable salts thereof; pharmaceutical compositions comprising such compounds; and methods of treating conditions characterized by disregulation of a fatty acid synthase pathway by the administration of such compounds and combinations of such compounds and other therapeutic agents.